Immunohistochemical analysis of CA125, CA19–9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation

References

• Pauerstein C J. Clinical presentation and diagnosis. Endometriosis: contemporary concepts in clinical management, R S Schenken. JB Lippincott, Philadelphia 1989; 127–4
   Google Scholar
• Lauchlan S C. The secondary müllerian system revisited. Int J Gynecol Pathol 1994; 13: 73–9
   PubMed Web of Science ®Google Scholar
• Bast R C, Jr, Feeney M, Lazarus H, Nadler L M, Colvin R B, Knapp R C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68: 1331–7
   PubMed Web of Science ®Google Scholar
• Bast R C, Jr, Klug T L, St Jonn E, Jenison E, Niloff J M, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New Engl J Med 1983; 309: 883–7
   PubMed Web of Science ®Google Scholar
• Kabawat S E, Bast R C, Jr, Welch W R, Knapp R C, Colvin R B. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol 1983; 79: 98–104
   PubMed Web of Science ®Google Scholar
• Kabawat S E, Bast R C, Jr, Bahn A K, Welch W R, Knapp R C, Colvin R B. Tissue distribution of a coelomic-epithel-ium related antigen recognized by the monoclonal antibody OCI25. Int J Gynecol Pathol 1983; 2: 275–85
   PubMed Web of Science ®Google Scholar
• Niloff J M, Klug T L, Schaetzl E, Zurawski V R, Knapp R C, Bast R C, Jr. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol 1984; 148: 1057–8
   PubMed Web of Science ®Google Scholar
• Barbieri R L, Niloff J M, Bast R C, Jr, Schaetzl E, Kistner R W, Knapp R C. Elevated serum concentrations of CA125 in patients with advanced endometriosis. Fertil Steril 1986; 45: 630–4
   PubMed Web of Science ®Google Scholar
• Patton P E, Field C S, Harms R W, Coulam C B. CA-125 levels in endometriosis. Fertil Steril 1986; 45: 770–3
   PubMed Web of Science ®Google Scholar
• Pittaway D E, Fayez J A. The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril 1986; 46: 790–5
   PubMed Web of Science ®Google Scholar
• Kauppila A, Telimaa S, Rannberg L, Vuori J. Placebo-controlled study on serum concentrations of CA125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery. Fertil Steril 1988; 49: 37–41
   PubMed Web of Science ®Google Scholar
• Panidis D, Vlassis G, Matalliotakis J, Skiadopoulos S, Kal-Ogeropoulos A. Serum levels of the oncofetal antigens CA125, CA19–9 and CA15–3 in patients with endometriosis. J Endocrinol Invest 1988; 11: 801–4
   PubMed Web of Science ®Google Scholar
• Moloney M D, Thornton J G, Cooper E H. Serum CA 125 antigen levels and disease severity in patients with endometriosis. Obstet Gynecol 1989; 73: 767–9
   PubMed Web of Science ®Google Scholar
• Franssen A MHW, van der Heijden P FM, Thomas C MC, Doesburg W H, Willemsen W NP, Rolland R. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol. Fertil Steril 1992; 57: 974–9
   PubMed Web of Science ®Google Scholar
• Myers T J, Arena B, Granai C O. Pelvic endometriosis mimicking advanced ovarian cancer: presentation with pleural effusion, ascites, and elevated serum CA 125 level. Am J Obstet Gynecol 1995; 173: 966–7
   PubMed Web of Science ®Google Scholar
• Fedele L, Arcaini L, Vercellini P, Bianchi S, Candiani G B. Serum CA125 measurements in the diagnosis of endometriosis recurrence. Obstet Gynecol 1988; 72: 19–22
   PubMed Web of Science ®Google Scholar
• Fedele L, Arcaini L, Baglioni A, Bianchi S, Menard S. What is the source of elevated serum levels of CA 125 in patients with endometriosis? Eur J Obstet Gynecol Reprod Biol 1989; 33: 247–52
   Google Scholar
• Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hy-bridoma antibodies. Somat Cell Genet 1979; 5: 957–71
   PubMedGoogle Scholar
• Del Villano B C, Brennan S, Brock P, Bucher C, Liu V, McClure M, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA19–9. Clin Chem 1983; 29: 549–52
   PubMed Web of Science ®Google Scholar
• Canney P A, Wilkinson P M, James R D, Moore M. CA19–9 as a marker for ovarian cancer: alone and in comparison with CA125. Br J Cancer 1985; 52: 131–3
   PubMed Web of Science ®Google Scholar
• Gadducci A, Ferdeghini M, Prontera C, Moretti L, Mariani G, Bianchi R, et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol 1992; 44: 147–54
   PubMed Web of Science ®Google Scholar
• Guerriero S, Ajossa S, Paoletti A M, Mais V, Angiolucci M, Melis G B. Tumor markers and transvaginal ultrasonography in the diagnosis of endometrioma. Obstet Gynecol 1996; 88: 403–7
   PubMed Web of Science ®Google Scholar
• Li S-F, Nakayama K., Masuzawa H, Fujii S. The number of proliferating cell nuclear antigen positive cells in endo-metriotic lesions differs from that in the endometrium. Analysis of PCNA positive cells during the menstrual cycle and in post-menopause. Virchows Arch A Pathol Anat 1993; 423: 257–63
   Google Scholar
• Toki T, Horiuchi A, Li S-F, Nakayama K, Silverberg S G, Fujii S. Proliferative activity of postmenopausal endometriosis: a histopathologic and immunocytochemical study. lnt J Gynecol Pathol 1996; 15: 45–53
   PubMed Web of Science ®Google Scholar
• Braun N, Papadopoulos T, Muller-Hermelink H K. Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cells. Virchows Arch B Cell Pathol 1988; 56: 25–33
   Google Scholar
• Nisolle M, Casanas-Roux F, Donnez J. Immunohistochem-ical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 1997; 68: 912–19
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999; 94: 71–7
   PubMed Web of Science ®Google Scholar
• American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1988; 43: 351–2
   Google Scholar
• Pittaway D E, Fayez J A. Serum CA-125 antigen levels increase during menses. Am J Obstet Gynecol 1987; 156: 75–6
   PubMed Web of Science ®Google Scholar